Inspire Medical Systems, Inc. (INSP): Cost of Revenue
$133.22M
Year ended 2025-12-31
$124.64M
Trailing 12 months to 2026-06-30
+26.3%
3-year compound annual growth
+49.9%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $133.22M | +8.3% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $122.99M | +27.3% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $96.58M | +46.1% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $66.11M | +98.7% | 2025-02-10, From 2022-01-01 |
| 2021-12-31 | $33.28M | +88.8% | 2024-02-09, From 2021-01-01 |
| 2020-12-31 | $17.62M | +29.2% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $13.64M | +35.7% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $10.06M | +67.1% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $6.02M | +54.1% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $3.90M | n/a | 2019-02-26, From 2016-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $133.22M | +8.3% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $256.30M | +1.1% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $468.72M | +4.0% |
| Embecta Corp. (EMBC) | 2025-09-30 | $403.60M | +4.0% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $232.27M | +24.0% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $219.89M | +19.3% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $166.88M | +21.6% |
| Haemonetics Corp (HAE) | 2026-03-28 | $546.44M | -10.7% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $432.39M | +20.9% |
Compare INSP, OFIX, TNDM, EMBC side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗